Background: The occurrence of malignancy following kidney transplantation has been estimated three to five times the incidence compared to that of the general population. It is estimated that particularly in renal cell carcinoma (RCC), the relative risk increases. The aim of this study was to analyze the characteristics, risk factors, and prognosis of RCC following kidney transplantation.
Data are presented as mean±SD. Abbreviations: RCC, renal cell carcinoma; LRD, living related donor; LURD, living unrelated donor; DD, deceased donor; HD, hemodialysis; CAPD, continuous ambulatory peritoneal dialysis; HLA, human leukocyte antigen; Aza, azathioprine; CsA, cyclosporine A; Tac, tacrolimus. 
